Compugen Ltd (CGEN) income statement
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.84−0.04 (-2.13%)
Close on Nov 20, 2026Market cap $173.98MP/E 4.8Yield –
Compugen Ltd financial ratios
See a number that looks wrong?